2024-11-15T14:39:08+00:00 2023-12-31 350921680 CROWE LLP 225 West Wacker Drive Suite 2600 Chicago IL 606061224 990 2023-01-01 462882271 Indiana Biosciences Research Institute Inc INDI 3179833350 1210 Waterway Blvd 2000 Indianapolis IN 46202 Alan Palkowitz President & CEO 2024-11-15 true Jennifer Burke P01342224 3128997000 2024-11-15 2023 2024-10-15 13:58:12Z Alan Palkowitz 1210 Waterway Blvd 2000 Indianapolis IN 46202 64136245 false X www.indianabiosciences.org X 2013 IN THE IBRI IS AN INDEPENDENT LIFE SCIENCES RESEARCH INSTITUTE FOCUSED ON ADDRESSING MAJOR UNDERSERVED AREAS OF PUBLIC HEALTH INCLUDING DIABETES, PEDIATRIC RARE DISEASES, AND ALZHEIMER'S DISEASE. THE IBRI FACILITATES THE GROWTH OF THE BIOMEDICAL COMMUNITY BY ATTRACTING TALENT AND INDUSTRY TO THE STATE AND AIDES IN THE COMMERCIALIZATION OF TECHNOLOGIES TO FOSTER FURTHER ECONOMIC DEVELOPMENT. 18 9 73 18 -12522 0 1140289 2480756 1195106 1280924 1764523 694936 -1610 7236 4098308 4463852 0 0 4777296 6091633 24843 55842 717293 8072531 9645223 12874670 15792698 -8776362 -11328846 149263304 150111240 29016876 26683295 120246428 123427945 TO BECOME A LEADING INDEPENDENT RESEARCH INSTITUTE IN THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE SOLUTIONS TO IMPROVE HUMAN HEALTH. false false 12889385 0 1313427 FOUNDED IN 2013, THE INDIANA BIOSCIENCES RESEARCH INSTITUTE'S (IBRI) SCIENTIFIC RESEARCH FOCUSES ON DISCOVERING INNOVATIVE SOLUTIONS FOR UNDERSERVED DISEASES, INCLUDING DIABETES, PEDIATRIC RARE DISEASES AND ALZHEIMER'S DISEASE. 12889385 true true false false false false false false true true true false true true true true false false true true false false true false false false false false true false false false false false false false false true false false false false true true false false false true 46 0 true 73 true false false false false false false false false false false false false X 18 9 false false false false false true false true true false false true true true true true true true true true true IN X Michele Sawyer 3179833350 1210 Waterway Blvd INDIANAPOLIS IN 46202 ALAN PALKOWITZ PhD PRESIDENT & CEO 32.0 8.0 X X 490544 92441 49546 DANIEL F EVANS JR EXECUTIVE CHAIR 0.5 X X 0 0 0 Michael Harrington Treasurer 0.5 X X 0 0 0 Aaron Schacht Director 0.5 X 0 0 0 CRISTOPHER JOHNSTON DIRECTOR 0.5 39.5 X 0 166085 50084 DANIEL GOLDEN DIRECTOR 0.5 X 0 0 0 DANIEL PETERSON DIRECTOR 0.5 X 0 0 0 DAVID INGRAM MD DIRECTOR 0.5 39.5 X 0 57242 33041 Debra Luffer-Atlas PhD Director (began 11/29/23) 0.5 X 0 0 0 HANY MOSELHI MD DIRECTOR 0.5 X 0 0 0 JAY HESS MD PhD MHSA, DIRECTOR 0.5 39.5 X 0 1055714 387160 Jeffrey Rhoads PhD Director (began 8/18/23) 0.5 39.5 X 0 306560 36373 JOHN C LECHLEITER PhD DIRECTOR 0.5 X 0 0 0 Karen Plaut Director (Began 4/17/23) 0.5 39.5 X 0 403107 68484 KENNETH CUSTER PhD DIRECTOR (partial year) 0.5 X 0 0 0 Michael Huber VP for University Relations 0.5 39.5 X 0 457967 71576 PATRICIA MARTIN DIRECTOR 0.5 39.5 X 0 235056 35223 TATIANA FOROUD PhD DIRECTOR 0.5 39.5 X 0 571561 53253 THERESA MAYER PhD DIRECTOR (partial year) 0.5 39.5 X 0 118076 7419 WENDY SRNIC PhD DIRECTOR 0.5 X 0 0 0 JOHN (JAY) M MCGILL PhD CHIEF OPERATING OFFICER 39.5 0.5 X 375771 0 32854 MICHELE J SAWYER CHIEF FINANCIAL OFFICER 40.0 X 313626 0 18266 BRIAN FILLENWARTH FINANCIAL CONTROLLER 40.0 X 181341 0 37111 Mark Kowala PhD Vice president - Translational 40.0 X 142094 0 7716 MARY M MADER VP MOLECULAR INNOVATION 40.0 X 274941 0 31385 MUSTAPHA MOUSSAIF PhD SR STAFF SCIENTIST 40.0 X 140907 0 30169 Sharon Elaine Semones Vice President - Business Development 40.0 X 163872 0 29829 2083096 3463809 979489 15 false true false Strategic Investment Group 1001 Nineteenth Street North 16th Floor Arlington VA 22209 Investment Services 341059 TBH Creative 600 E Carmel Drive Carmel IN 46032 Marketing Services 252557 BROWNING INVESTMENTS LLC 8940 River Crossing Blvd Suite 300 Indianapolis IN 46240 Tenant Improvements 202259 Medex Staffing 7839 Solution Center Chicago IL 606777008 Staffing Services 123150 4 698819 1781937 162895 2480756 Research Collaboration 541700 1135640 1135640 Research Services 541700 145284 145284 0 0 0 0 1280924 1112738 -12522 1125260 404525 429792 -25267 0 -25267 -25267 58824799 59242601 -417802 0 -417802 -417802 Miscellaneous Income 900099 32503 32503 0 0 0 0 32503 4463852 1313427 -12522 682191 1250861 1006987 168273 75601 3980105 3204123 535427 240555 171822 138323 23114 10385 362383 291731 48750 21902 326462 262813 43918 19731 48506 36005 9139 3362 122912 122912 62571 46445 11789 4337 55842 55842 554541 411619 104483 38439 742736 551311 139941 51484 399773 272346 95896 31531 32934 22436 7900 2598 558682 380603 134014 44065 2321145 1768775 506339 46031 163998 144513 10493 8992 18664 16447 1194 1023 319649 217761 76676 25212 1970811 1849931 101282 19598 105685 71998 25351 8336 Lab Expenses 2167298 2157533 5859 3906 Loss on Disposal of Equipment 36036 24550 8644 2842 Other Expenses 13732 9355 3294 1083 Bank Fees 5550 3780 1332 438 0 0 0 0 15792698 12889385 2186020 717293 2425366 1003919 0 0 702021 544200 0 0 0 0 212987 61320 18366271 8520035 11296306 9846236 17596618 22449339 98156150 98789840 0 18873856 17416386 149263304 150111240 1991666 2121525 0 0 915189 624148 0 0 0 0 7286454 6250000 18823567 17687622 29016876 26683295 X 74986763 72025032 45259665 51402913 120246428 123427945 149263304 150111240 X -11328846 14706480 -196117 X false true X true false X X X 5 CENTRAL INDIANA CORPORATE PARTNERSHIP INC 352065459 9 true 0 0 STATE OF INDIANA 000000000 6 true 0 0 INDIANA UNIVERSITY 356001673 2 true 598359 0 PURDUE UNIVERSITY 356002041 2 true 19720 0 UNIVERSITY OF NOTRE DAME DU LAC 350868188 2 true 0 0 5 618079 0 true true true true true false false false false false false false false false false false false true false Schedule A, Part IV, Section A, Line 3b Section A, Line 3b For the supported organization qualified under section 501(c)(6), Central Indiana Corporate Partnership, we reviewed the most recent Form 990 filed for the organization to determine the organization satisfied the public support test requirements. Schedule A, Part IV, Section A, Line 3c Section A, Line 3C Our purchasing and cash disbursements policies ensure that support provided by IBRI to supported organizations is used exclusively for section 170(c)(2)(B) purposes. Schedule A, Part IV, Section A, Line 2 Supported Org. Without IRS Status 509(a)1 or (2) Of IBRI's supported organizations, Indiana University, Purdue University, and the State of Indiana do not have determination letters from the Internal Revenue Service ("IRS") confirming their exempt status under section 509(a)(1) or (2). Indiana University and Purdue University are both state universities and thus are not required to obtain recognition of their tax-exempt status. The State of Indiana is a governmental unit described in section 170(b)(1)(A)(v) and is not required to obtain recognition of its tax-exempt status. Schedule A, Part IV, Section A, Line 3b Qualified Under 501C(4)(5) Or (6) Central Indiana Corporate Partnership, Inc. ("CICP") is recognized by the IRS as a tax-exempt business league described in section 501(c)(6). IBRI requested and received confirmation from CICP that it would satisfy the public support test under section 509(a)(2). CICP annually analyzes its financial records to assess whether it would satisfy the public support test under section 509(a)(2). Schedule A, Part IV, Section A, Line 3c Support To Org. Used Exclusively Sec. 170(c)(2)(B) Purposes IBRI ensures that all support to CICP is used exclusively for section 170(c)(2)(B) purposes by reminding CICP of such limitation on the support that IBRI provides to CICP and by regularly confirming with CICP that any and all support IBRI provides to CICP was used exclusively for charitable and exempt purposes described in section 170(c)(2)(B). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 115752770 100082 15386327 10000000 121239179 142205804 1495845 -14435912 13512967 115752770 141951538 745787 7184390 7675911 142205804 128938033 15523690 11889815 14400000 141951538 111610169 16576898 10750966 7700000 2300000 128938033 0.576 0.3234 0.1006 false false 8900369 1620178 7280191 9465902 6899857 2566045 9846236 Commingled Investment Funds 98789840 F 98789840 Lease Right of Use Asset 16901629 Interest Rate Swap 514757 17416386 Bldg lease liability 17674059 Interest Rate Swap 13563 17687622 X 19045584 14706480 429792 15136272 3909312 554540 0 554540 4463852 15667950 0 0 15667950 554540 -429792 124748 15792698 Schedule D, Part V, Line 4 Intended uses of endowment funds THE ENDOWMENT FUNDS ARE INTENDED TO SUPPORT THE ONGOING OPERATIONS OF THE IBRI. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Institute is exempt from income taxes under §501(c)(3) of the U.S. Internal Revenue Code and is classified as a public charity under §509(a)(1) and §170(b)(1)(A)(vi). The Institute has adopted accounting guidance related to accounting for uncertainty in income taxes. This guidance requires the Institute to recognize a tax benefit only if it is more likely than not the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50 percent likely of being realized on examination. For tax positions not meeting the more-likely-than-not test, no tax benefit is recorded. The Institute has examined this issue and has determined there are no material contingent liabilities or questionable tax positions. The Institute does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Institute recognizes interest and/or penalties related to income tax matters in income tax expense. The Institute did not have any amount accrued for interest and penalties at December 31, 2023 or 2022. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 Rental Expense - 429792 Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements Rental Expense - -429792 Europe (Including Iceland and Greenland) 0 2 Program Services SCIENTIFIC ADVISORY SERVICES 15041 Europe (Including Iceland and Greenland) 0 0 Investments n/a 24481904 North America (Canada & Mexico only) 0 1 Program Services IT Services 6031 South Asia 0 0 Investments 612115 East Asia and the Pacific 0 0 Investments 11971738 0 3 0 0 0 3 37086829 0 37086829 true false true true false false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH ASIA-Accrual X X X true GONSER GERBER 1776 Legacy Circle Suite 100 NAPERVILLE IL 60563 CONSULTING false 60545 -60545 0 60545 -60545 CA CO CT FL GA AL HI IL IN IA KS KY LA ME AK MD MA MI MN MS MO NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA AR WA WV WI X X X X X false false false false false false false false false ALAN PALKOWITZ PhD PRESIDENT & CEO 490425 42441 0 0 119 50000 19800 5355 0 24391 510344 122187 0 0 PATRICIA MARTIN DIRECTOR 0 100534 0 38250 0 96272 0 23683 0 11540 0 270279 0 0 TATIANA FOROUD PhD DIRECTOR 0 241476 0 94085 0 236000 0 39904 0 13349 0 624814 0 0 JAY HESS MD PhD MHSA, DIRECTOR 0 606607 0 230547 0 218560 0 362378 0 24782 0 1442874 0 0 CRISTOPHER JOHNSTON DIRECTOR 0 166085 0 0 0 0 0 24709 0 25375 0 216169 0 0 Karen Plaut Director (Began 4/17/23) 0 364475 0 35000 0 3632 0 33000 0 35484 0 471591 0 0 Michael Huber VP for University Relations 0 442346 0 0 0 15621 0 45563 0 26013 0 529543 0 0 Jeffrey Rhoads PhD Director (began 8/18/23) 0 280706 0 0 0 25854 0 23917 0 12456 0 342933 0 0 JOHN (JAY) M MCGILL PhD CHIEF OPERATING OFFICER 375652 0 0 0 119 0 19800 0 13054 0 408625 0 0 0 MICHELE J SAWYER CHIEF FINANCIAL OFFICER 304333 0 9174 0 119 0 18266 0 0 0 331892 0 0 0 BRIAN FILLENWARTH FINANCIAL CONTROLLER 170352 0 10948 0 41 0 10839 0 26272 0 218452 0 0 0 MUSTAPHA MOUSSAIF PhD SR STAFF SCIENTIST 140830 0 0 0 77 0 8246 0 21923 0 171076 0 0 0 MARY M MADER VP MOLECULAR INNOVATION 274822 0 0 0 119 0 15431 0 15954 0 306326 0 0 0 Sharon Elaine Semones Vice President - Business Development 163845 0 0 0 27 0 10350 0 19479 0 193701 0 0 0 X 100082 Market value X Laboratory Equipment 1 62813 Cost 0 false true false Schedule M, Part I Explanations of reporting method for number of contributions Other - Laboratory Equipment Number of contributions Form 990, Part VI, Line 1a Delegate broad authority to a committee THE BOARD OF DIRECTORS DELEGATES BROAD AUTHORITY TO AN EXECUTIVE COMMITTEE TO ACT ON THE ORGANIZATION'S BEHALF. THE COMMITTEE IS ESTABLISHED BY THE BOARD TO EXERCISE THE POWERS OF THE BOARD IN RELATED TO MATTERS THAT ARISE BETWEEN REGULARLY SCHEDULED BOARD MEETINGS AND/OR WHEN IT IS NOT PRACTICAL OR FEASIBLE FOR THE BOARD TO MEET. THE COMMITTEE IS COMPRISED OF TWO (2) OR MORE DIRECTORS OF THE CORPORATION. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body SUPPORTED ORGANIZATIONS HAVE THE RIGHT TO APPOINT DIRECTORS AS SPECIFIED IN INDIANA BIOSCIENECS RESEARCH INSTITUTE'S AMENDED AND RESTATED BYLAWS. Form 990, Part VI, Line 11b Review of form 990 by governing body IBRI'S FORM 990 WAS PREPARED BY THE FINANCE DEPARTMENT AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM AND BY THE IBRI'S LEGAL COUNSEL. SUBSEQUENTLY, A SUBSTANTIALLY COMPLETE FORM 990 AND SUPPLEMENTAL SCHEDULES WERE PRESENTED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. Form 990, Part VI, Line 12c Conflict of interest policy It is the policy of IBRI and its Board of Directors that the Corporation's directors, officers, and employees carry out their respective duties in a fashion that avoids actual, potential, or perceived conflicts of interest. IBRI's directors, officers, and employees shall have the continuing, affirmative duty to report any personal ownership, interest, or other relationship that might affect their ability to exercise impartial, ethical, and business-based judgments in fulfilling their responsibilities to the organization. Each year directors, officers, and employees acknowledge and agree that they have a duty to avoid business, financial or other interests or relationships that conflict with the interests of the Institute or that divide their loyalty to the Institute. Any activity that appears to present a conflict must be disclosed to the Institute and must be avoided or terminated unless the Institute in its sole discretion determines the activity is not harmful to the Institute or otherwise improper. The Board of Directors shall be responsible for oversight of all disclosures or failures to disclose and for taking appropriate action in the case of any actual or potential conflict of interest transaction. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE BOARD OF DIRECTORS DETERMINES COMPENSATION FOR THE CEO USING COMPARABILITY DATA AND COMPENSATION SURVEYS. A COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS CONTEMPORANEOUSLY DOCUMENTS THE DELIBERATION AND DECISION OF THIS PROCESS. THIS PROCESS OCCURS ANNUALLY AND LAST OCCURRED IN AUGUST 2023. Form 990, Part VI, Line 15b Process to establish compensation of other employees A COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS DETERMINES COMPENSATION FOR THE COO AND CFO USING COMPARABILITY DATA AND COMPENSATION SURVEYS. THE BOARD CONTEMPORANEOUSLY DOCUMENTS THE DELIBERATION AND DECISION OF THIS PROCESS. THIS PROCESS OCCURS ANNUALLY AND LAST OCCURRED IN AUGUST 2023. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON WRITTEN REQUEST. Form 990, Part XI, Line 9 Other changes in net assets or fund balances Change in fair value of interest rate swap - -196117; FORM 990, PART VII, LINE 1A BOARD MEMBER COMPENSATION Compensation reported in Part VII and Schedule J for Board Members who are employees of Indiana University, Purdue University, Central Indiana Corporate Partnership Inc, and University of Notre Dame, Du Lac is compensation annually reported and disclosed as required under state statute. In addition, some of these individuals participate in retirement and benefit plans provided by the supported organizations. FORM 990, SCHEDULE J, PART II BOARD MEMBER COMPENSATION Compensation reported in Part VII and Schedule J for Board Members who are employees of Indiana University, Purdue University, Central Indiana Corporate Partnership Inc, and University of Notre Dame, Du Lac is compensation annually reported and disclosed as required under state statute. In addition, some of these individuals participate in retirement and benefit plans provided by the supported organizations. 16 TECH COMMUNITY CORPORATION 300 NORTH MERIDIAN STREET SUITE 950 INDIANAPOLIS IN 46204 810853467 FOSTER ECONOMIC DEVELOPMENT IN THE CITY OF INDIANAPOLIS IN 501(c)(3) Type I NA false STATE OF INDIANA 1 North Capitol Ave Suite 700 Indianapolis IN 46204 Indiana State government IN 501(c)(1) na false CENTRAL INDIANA CORPORATE PARTNERSHIP INC 1210 Waterway Blvd Ste 5000 Indianapolis IN 46202 352065459 Economic development IN 501(c)(6) na false INDIANA UNIVERSITY 400 E 7th St Rm 501 Bloomington IN 47405 356001673 Education IN 501(c)(3) 2 NA false PURDUE UNIVERSITY 1281 Win Hentschel Blvd Suite 1100 West Lafayette IN 47906 356002041 Education IN 501(c)(3) 2 na false UNIVERSITY OF NOTRE DAME DU LAC Controllers Office 724 Grace Hall Notre Dame IN 46556 350868188 Education IN 501(c)(3) 2 na false false false true false false false false false false false false true true false true false false false false